Exploring a new pathway for biomarker-based approval of immunotherapies

Josep M. Llovet

doi:10.1038/s41571-023-00731-8

Exploring a new pathway for biomarker-based approval of immunotherapies

Research output: Contribution to journal › Comment/debate

Original language	English
Journal	Nature Reviews Clinical Oncology
DOIs	https://doi.org/10.1038/s41571-023-00731-8
State	Accepted/In press - 2023

Access to Document

10.1038/s41571-023-00731-8

Cite this

@article{62e65491b6624182879cb4446cb1ca45,

title = "Exploring a new pathway for biomarker-based approval of immunotherapies",

author = "Llovet, {Josep M.}",

note = "Funding Information: The work of J.M.L. is supported by grants from the US NIH (RO1DK56621 and RO1DK128289), Cancer Research UK, Fondazione AIRC and Fundaci{\'o}n Cient{\'i}fica de la Asociaci{\'o}n Espa{\~n}ola Contra el C{\'a}ncer (HUNTER, ref. C9380/A26813), the Samuel Waxman Cancer Research Foundation, Generalitat de Catalunya (AGAUR, SGR-1358), and the Spanish National Health Institute (MICINN, PID2019-105378RB-I00). ",

year = "2023",

doi = "10.1038/s41571-023-00731-8",

language = "English",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Exploring a new pathway for biomarker-based approval of immunotherapies

AU - Llovet, Josep M.

N1 - Funding Information: The work of J.M.L. is supported by grants from the US NIH (RO1DK56621 and RO1DK128289), Cancer Research UK, Fondazione AIRC and Fundación Científica de la Asociación Española Contra el Cáncer (HUNTER, ref. C9380/A26813), the Samuel Waxman Cancer Research Foundation, Generalitat de Catalunya (AGAUR, SGR-1358), and the Spanish National Health Institute (MICINN, PID2019-105378RB-I00).

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85146956573&partnerID=8YFLogxK

U2 - 10.1038/s41571-023-00731-8

DO - 10.1038/s41571-023-00731-8

M3 - Comment/debate

AN - SCOPUS:85146956573

SN - 1759-4774

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

ER -